VANCOUVER, BC and PRINCETON, NJ / ACCESSWIRE / January 23, 2023 / Xybion Digital Inc. (TSXV:XYBN) (“Xybion” or the “Firm”), a world, low-code SaaS firm that allows digital transformation in extremely regulated industries like Life Sciences, introduced at the moment that Firm Chairman and CEO, Dr. Pradip Banerjee has been invited to current on the Healthcare IT Digital Convention, offered by Maxim Group LLC and hosted by M-Vest, on Wednesday, January twenty fifth, 2023 at 2:00 p.m. ET.
Please be a part of us for the upcoming convention on Healthcare IT. Collaborating firms give attention to expertise addressing rising well being care prices, and shortage of staff and sources. Find out about firms which might be utilizing expertise and AI within the effort to enhance healthcare outcomes and shift to value-based care. We additionally spotlight firms that search to supply low-cost, distant options and well timed monitoring of affected person threat components.
This convention can be stay on M-Vest. To attend, simply signal as much as turn into an M-Vest member.
8:30 a.m. ET – iSpecimen (ISPC) – Firm Introduction
9:00 a.m. ET – Marpai (MRAI) – Firm Introduction
9:30 a.m. ET – Reliq Well being Care (RHT.V & RQHTF) – Firm Introduction
10:00 a.m. ET – OnTrak (OTRK) – Firm Introduction
10:30 a.m. ET – Cloud DX (CDX.V & CDXFF) – Firm Introduction
11:00 a.m. ET – Coronary heart Sciences (HSCS) – Firm Introduction
11:30 a.m. ET – Effectively Well being (WELL.TO & WHTCF) – Firm Introduction
12:00 p.m. ET – Analysis Options (RSSS) – Firm Introduction
12:30 p.m. ET – Expertise for Physicians
1:15 p.m. ET – Distant Coronary heart Monitoring Panel
2:00 p.m. ET – Digital Supply of HC Merchandise & Analysis Administration
2:45 p.m. ET – Enhance Affected person Outcomes & Experiences Panel
3:30 p.m. ET – Cryo-Cell (CCEL) – Firm
4:00 p.m. ET – Respiri (RSH:ASX) – Firm Introduction
4:30 p.m. ET – Superior Human Imaging (AHI) – Firm Introduction
About Xybion Digital Inc.
Xybion is a world SaaS firm that helps enterprise life sciences organizations speed up new drug growth into authorised medicines that will save lives and hold workers protected. We digitize drug analysis and growth, laboratory testing, regulatory approvals, and pharmaceutical manufacturing on a single, unified cloud platform that’s cost-effective, able to deploy, and simple to make use of. Xybion has over 160 shoppers in 29 international locations utilizing its low-code software program to speed up timelines, enhance compliance, develop capability, reduce working dangers, and cut back bills whereas protecting workers protected.
These modules are unified collectively creating a sturdy lab execution system that gives seamless expertise for all preclinical laboratory workers and a quite simple IT ecosystem to keep up for the IT group.
Study extra about Xybion at https://www.xybion.com/
For additional info: For extra info concerning Xybion Digital Inc., please contact Dr. Pradip Okay. Banerjee, Chairman & Chief Government Officer, [email protected], 609-512-5790 x122
Neither TSX Enterprise Change nor its Regulation Companies Supplier (as that time period is outlined in insurance policies of the TSX Enterprise Change) accepts accountability for the adequacy or accuracy of this launch.
Sure statements (“forward-looking statements”) on this information launch could comprise forward-looking info regarding regarding Xybion’s place within the life sciences sector, the providers to be carried out by Xybion as described above and the outcomes thereof, plans associated to the Firm’s enterprise and different issues that will happen sooner or later, made as of the date of this information launch. In making the forward-looking statements included on this information launch, the Firm has utilized a number of materials assumptions, together with that Xybion will be capable to carry out its providers as at the moment anticipated. Though administration considers these assumptions to be affordable primarily based on info accessible to it, they might show to be incorrect.
Ahead-looking statements are topic to quite a lot of identified and unknown dangers, uncertainties and different components which may trigger precise occasions or outcomes to vary from these expressed or implied by the forward-looking statements. Readers are cautioned to not place undue reliance on these forward-looking statements as numerous necessary components may trigger the precise outcomes to vary materially from the expectations expressed in them. Such components embody, amongst others, the chance that the Firm could not be capable to carry out its providers as at the moment anticipated, that outcomes of such providers might not be according to anticipated outcomes, or these described in disclosure paperwork filed by the Firm on SEDAR. There may be no assurance that forward-looking statements will show to be correct and precise outcomes and future occasions may differ materially from these anticipated in such statements. The Firm expressly disclaims any intention or obligation to replace or revise any forward-looking statements whether or not because of new info, future occasions or in any other case, besides as in any other case required by relevant securities laws.
This information launch doesn’t represent a suggestion to promote or a solicitation of a suggestion to purchase any of the securities described herein in the US. The securities described herein haven’t been registered underneath the US Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities legislation and might not be provided or bought within the “United States”, as such time period is outlined in Regulation S promulgated underneath the U.S. Securities Act, except registered underneath the U.S. Securities Act and relevant state securities legal guidelines or an exemption from such registration necessities is on the market.
SOURCE: Xybion Digital Inc
View supply model on accesswire.com: